Evaluation of severe hypoglycemia and common mental disorders in patients receiving insulin analogues for treatment of type 1 diabetes

Arch Endocrinol Metab. 2021 Nov 1;65(1):117-119. doi: 10.20945/2359-3997000000315. Epub 2020 Dec 15.

Abstract

This is a retrospective report of the frequency of severe hypoglycemia and the association between common mental disorders and type 1 diabetes mellitus treated with insulin analogues. Patients with severe hypoglycemia compared with those without this complication had a higher prevalence of positive screening for common mental disorders (88% vs. 77%, respectively, p = 0.03).

Keywords: Severe hypoglycemia; common mental disorders; type 1 diabetes.

MeSH terms

  • Diabetes Mellitus, Type 1* / drug therapy
  • Humans
  • Hypoglycemia* / chemically induced
  • Hypoglycemic Agents / adverse effects
  • Insulin / adverse effects
  • Mental Disorders* / chemically induced
  • Mental Disorders* / drug therapy
  • Retrospective Studies

Substances

  • Hypoglycemic Agents
  • Insulin